65 related articles for article (PubMed ID: 429137)
1. Pharmacokinetic studies of oxalate in man.
Hautmann R; Osswald H
Invest Urol; 1979 Mar; 16(5):395-8. PubMed ID: 429137
[TBL] [Abstract][Full Text] [Related]
2. Oxalic acid concentration in serum measured by isotopic clearance technique. Experience in hyper- and normo-oxaluric subjects.
Prenen JA; Mees EJ; Boer P; Endeman HJ; Ephraim KH
Proc Eur Dial Transplant Assoc; 1979; 16():566-70. PubMed ID: 549000
[TBL] [Abstract][Full Text] [Related]
3. Renal elimination kinetics and plasma half-life of oxalate in man.
Osswald H; Hautmann R
Urol Int; 1979; 34(6):440-50. PubMed ID: 494445
[TBL] [Abstract][Full Text] [Related]
4. Determination of oxalic acid clearance and plasma concentration by radioisotope infusion. Results in a family with hyperoxaluria.
Prenen JA; Boer P; Dorhout Mees EJ; Endeman HJ; Yoe OH
Acta Med Scand; 1981; 209(1-2):87-91. PubMed ID: 7211493
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic study on oxalate in rats].
Sugimoto T; Katoh Y; Matsumura T; Kishimoto T; Yamamoto K; Kanazawa T; Senju M; Maekawa M
Hinyokika Kiyo; 1988 Jul; 34(7):1135-40. PubMed ID: 3051947
[TBL] [Abstract][Full Text] [Related]
6. Fate of circulating oxalate in rats.
Sugimoto T; Osswald H; Yamamoto K; Kanazawa T; Iimori H; Funae Y; Kamikawa S; Kishimoto T
Eur Urol; 1993; 23(4):485-9. PubMed ID: 8335055
[TBL] [Abstract][Full Text] [Related]
7. The disposition and metabolic fate of 14C-cibenzoline in man.
Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
[TBL] [Abstract][Full Text] [Related]
8. [Diurnal variation in plasma oxalate concentration and oxalate clearance in calcium oxalate stone formers with special reference to the effect of oxalate loading].
Kinoshita N
Hinyokika Kiyo; 1987 Sep; 33(9):1331-41. PubMed ID: 3434488
[TBL] [Abstract][Full Text] [Related]
9. Renal clearance of [14C]oxalate: comparison of constant-infusion with single-injection techniques.
Prenen JA; Boer P; Mees EJ; Endeman HJ; Spoor SM; Oei HY
Clin Sci (Lond); 1982 Jul; 63(1):47-51. PubMed ID: 7083764
[TBL] [Abstract][Full Text] [Related]
10. Plasma oxalate concentration, oxalate clearance and cardiac function in patients receiving haemodialysis.
Tomson CR; Channon SM; Ward MK; Laker MF
Nephrol Dial Transplant; 1989; 4(9):792-9. PubMed ID: 2516611
[TBL] [Abstract][Full Text] [Related]
11. Oxalate absorption from intestinal segments of rats.
Madorsky ML; Finlayson B
Invest Urol; 1977 Jan; 14(4):274-7. PubMed ID: 836465
[TBL] [Abstract][Full Text] [Related]
12. Plasma level and renal clearance of oxalate in normal subjects and in patients with primary hyperoxaluria or chronic renal failure or both.
Constable AR; Joekes AM; Kasidas GP; O'Regan P; Rose GA
Clin Sci (Lond); 1979 Apr; 56(4):299-304. PubMed ID: 477214
[TBL] [Abstract][Full Text] [Related]
13. [Plasma oxalate concentration in calcium oxalate stone formers].
Hoshina A
Hinyokika Kiyo; 1984 Oct; 30(10):1405-15. PubMed ID: 6524552
[TBL] [Abstract][Full Text] [Related]
14. Determination of excretion of inulin, creatinine, sodium sulfanilate, and phenolsulfonphthalein to assess renal function in goats.
Brown SA; Groves C; Barsanti JA; Finco DR
Am J Vet Res; 1990 Apr; 51(4):581-6. PubMed ID: 2327619
[TBL] [Abstract][Full Text] [Related]
15. Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers.
Chen TL; Vogelsang GB; Petty BG; Brundrett RB; Noe DA; Santos GW; Colvin OM
Drug Metab Dispos; 1989; 17(4):402-5. PubMed ID: 2571480
[TBL] [Abstract][Full Text] [Related]
16. Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine.
Morgan SH; Maher ER; Purkiss P; Watts RW; Curtis JR
Nephrol Dial Transplant; 1988; 3(1):28-32. PubMed ID: 3132636
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of terbutaline in asthmatic children.
Hultquist C; Lindberg C; Nyberg L; Kjellman B; Wettrell G
Eur J Respir Dis Suppl; 1984; 134():195-203. PubMed ID: 6586480
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of azlocillin in healthy subjects.
Leroy A; Humbert G; Fillastre JP
Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
[TBL] [Abstract][Full Text] [Related]
19. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
[TBL] [Abstract][Full Text] [Related]
20. [Bioavailability of heptaminol in healthy subjects].
Kees F; Dominiak P; Grobecker H
Arzneimittelforschung; 1987 Oct; 37(10):1182-5. PubMed ID: 3435592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
